Re: Amendment No. 1 to Accounts Receivable Purchase Agreement

Exhibit 10.1

                              Access Capital, Inc.
                                 405 Park Avenue
                            New York, New York 10022

                                  June 5, 2006


Emergent Group, Inc.
PRI Medical Technologies, Inc.
932 Grand Central Ave
Glendale, California


Re:   Amendment No. 1 to Accounts Receivable Purchase Agreement

Gentlemen:

     Reference is made to the Accounts Receivable Purchase Agreement dated as of
May 25,   2005 (as the same may be   amended,   supplemented,   restated or modified
from time to time, the "Agreement") between Emergent Group, Inc. and PRI Medical
Technologies,   Inc.   (collectively   the   "Companies")   and Access Capital,   Inc.
("Access Capital"). All capitalized terms used herein that are not defined shall
have the respective   meanings given to them in the Accounts   Receivable Purchase
Agreement ("ARPA").

     This Amendment confirms the agreement of the parties that the ARPA shall be
modified to reflect the following:

1.       The last   sentence   of Section 2a of the ARPA,   shall be deleted and the
following inserted in its place:   "Proceeds of collections shall be available to
the Companies (so long as   consistent   with the terms of this   Agreement) on the
first business day after receipt by Access   Capital   without regard to clearance
and credited to outstanding balances on the same day of receipt thereof."

2.       Section 2b of the ARPA is hereby deleted in its entirety.

3.       The   Required   Minimum   Amount,   as   defined   in   Section 3 of Exhibit A
("Standard Terms and Conditions of the Accounts Receivable Purchase   Agreement")
shall be reduced from $500,000 to $0.

4.       The   second    paragraph   of   Section   8   in   Ex